Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6656338 | 0.96 | — | — | |
| SCHEMBL17167688 | 0.86 | — | — | |
| SCHEMBL2571407 | 0.86 | CA2 (0.38) | — | |
| SCHEMBL12229289 | 0.86 | ALDH1A1 (0.35) | ALDH1A1TSHRHSD17B10MEN1KMT2A | |
| SCHEMBL25113460 | 0.86 | — | — | |
| SCHEMBL25006051 | 0.86 | — | — | |
| SCHEMBL452098 | 0.86 | — | — | |
| SCHEMBL5411007 | 0.86 | MEN1 (0.58) | ALDH1A1TP53TSHRHIF1AHSD17B10 | |
| SCHEMBL21641963 | 0.86 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL13541741 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013056096-A1 | POLYPEPTIDE-OPIOID CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2013-04-18 | — | — | WO | claimed |
| WO-2025149262-A1 | CURABLE POLYMER COMPOSITION CONTAINING ALDEHYDES, COMPOUNDS WITH ACTIVATED METHYLENE GROUPS, AND AN ACCELERATOR COMPONENT | SIKA TECHNOLOGY AG (CH) | 2025-07-17 | — | — | WO | disclosed |
| EP-4585628-A1 | CURABLE POLYMER COMPOSITION COMPRISING ALDEHYDES, COMPOUNDS HAVING ACTIVATED METHYLENE GROUPS, AND AN ACCELERATOR COMPONENT | Sika Technology AG (CH) | 2025-07-16 | — | — | EP | disclosed |
| EP-4585627-A1 | ONE-COMPONENT CURABLE POLYMER COMPOSITION COMPRISING ALDEHYDES AND CYANOACETATES | Sika Technology AG (CH) | 2025-07-16 | — | — | EP | disclosed |
| EP-4554996-A1 | POLYMER COMPOSITION WHICH CAN BE CURED AT ROOM TEMPERATURE AND WHICH IS MADE OF POLYALDEHYDE AND POLYMALONATE | Sika Technology AG (CH) | 2025-05-21 | — | — | EP | disclosed |
| EP-4554995-A1 | POLYMER COMPOSITION WHICH CAN BE CURED AT ROOM TEMPERATURE AND WHICH IS MADE OF POLYALDEHYDE AND 1,3 KETO ESTER | Sika Technology AG (CH) | 2025-05-21 | — | — | EP | disclosed |
| CN-119365506-A | Polymer compositions curable at room temperature and made from polyaldehydes and 1, 3-ketoesters | SIKA技术股份公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-119301168-A | Polymer compositions curable at room temperature and made from polyaldehydes and polymalonates | SIKA技术股份公司 | 2025-01-10 | — | — | CN | disclosed |
| WO-2024012829-A1 | POLYMER COMPOSITION WHICH CAN BE CURED AT ROOM TEMPERATURE AND WHICH IS MADE OF POLYALDEHYDE AND POLYMALONATE | SIKA TECHNOLOGY AG (CH) | 2024-01-18 | — | — | WO | disclosed |
| WO-2024012827-A1 | POLYMER COMPOSITION WHICH CAN BE CURED AT ROOM TEMPERATURE AND WHICH IS MADE OF POLYALDEHYDE AND POLYCYANOACETATE | SIKA TECHNOLOGY AG (CH) | 2024-01-18 | — | — | WO | disclosed |
| WO-2024012828-A1 | POLYMER COMPOSITION WHICH CAN BE CURED AT ROOM TEMPERATURE AND WHICH IS MADE OF POLYALDEHYDE AND 1,3 KETO ESTER | SIKA TECHNOLOGY AG (CH) | 2024-01-18 | — | — | WO | disclosed |
| EP-2111237-B1 | FIBRIN-BINDING PEPTIDES AND CONJUGATES THEREOF | BRACCO IMAGING SPA (IT) | 2015-03-18 | — | — | EP | disclosed |
| WO-2013056096-A1 | POLYPEPTIDE-OPIOID CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2013-04-18 | — | — | WO | disclosed |
| US-8293214-B2 | Targeting and therapeutic compounds and gas-filled microvesicles comprising said compounds | BRACCO SUISSE S.A. (CH) | 2012-10-23 | — | — | US | disclosed |
| CN-102224180-A | Polyurethane composition comprising hydroxyaldimines | SIKA TECHNOLOGY AG | 2011-10-19 | — | — | CN | disclosed |
| EP-2194081-B1 | Polyurethane composition comprising hydroxyaldimines | SIKA TECHNOLOGY AG (CH) | 2011-09-07 | — | — | EP | disclosed |
| WO-2010063739-A1 | POLYURETHANE COMPOSITION COMPRISING HYDROXYALDIMINES | SIKA TECHNOLOGY AG (CH) | 2010-06-10 | — | — | WO | disclosed |
| EP-2194081-A1 | Polyurethane composition comprising hydroxyaldimines | Sika Technology AG (CH) | 2010-06-09 | — | — | EP | disclosed |
| US-20100008863-A1 | TARGETING AND THERAPEUTIC COMPOUNDS AND GAS-FILLED MICROVESICLES COMPRISING SAID COMPOUNDS | BRACCO SUISSE SA (CH) | 2010-01-14 | — | — | US | disclosed |
| WO-2007107706-A2 | DIMERS OF HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF COPD | ARGENTA DISCOVERY LIMITED (GB) | 2007-09-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100008863-A1 | TARGETING AND THERAPEUTIC COMPOUNDS AND GAS-FILLED MICROVESICLES COMPRISING SAID COMPOUNDS | SGMS1, SGMS2, MSR1 | ALDH1A1 4188/4885TP53 519/4885TSHR 2495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.